|
US7902121B2
(en)
*
|
2001-07-02 |
2011-03-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
MHC-antigen arrays for detection and characterization of immune responses
|
|
US20070196346A1
(en)
*
|
2003-08-21 |
2007-08-23 |
Brown Michael P |
Poxvirus Vector Encoding Prostate Specific Antigens For Treatment Of Prostate Cancer
|
|
WO2005033278A2
(en)
*
|
2003-09-30 |
2005-04-14 |
Ludwig Institute For Cancer Research |
In vivo efficacy of ny-eso-1 plus iscom
|
|
CU23297A1
(es)
*
|
2004-11-16 |
2008-07-24 |
Ct De Inmunologa A Molecular |
Formulaciones inmunoterapã0/00uticas para la inducciã"n de autoanticuerpos bloqueadores de la uniã"n de interleucina-2 a su receptor. su uso en el tratamiento del cã ncer
|
|
AU2006244151B2
(en)
|
2005-05-05 |
2012-05-17 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions for detecting immune responses
|
|
EP1989224B1
(en)
|
2006-02-24 |
2010-10-20 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Immunogenic peptides and methods of use
|
|
US20080095790A1
(en)
*
|
2006-10-24 |
2008-04-24 |
Perambakam Supriya M |
Methods of Treating Prostate Cancer
|
|
CN100522460C
(zh)
*
|
2007-12-15 |
2009-08-05 |
江西江铃底盘股份有限公司 |
一种桥壳总成的焊接夹具及焊接工艺
|
|
EP2477655A4
(en)
*
|
2009-09-14 |
2014-02-12 |
Baylor Res Inst |
VACCINES TREATED ON LANGERHANS CELLS
|
|
WO2012006634A2
(en)
*
|
2010-07-09 |
2012-01-12 |
The Board Of Trustees Of The University Of Illiniois |
Prostate specific antigen (psa) peptide therapy
|
|
US8557777B2
(en)
|
2010-07-09 |
2013-10-15 |
The Board Of Trustees Of The University Of Illinois |
Methods for treating cancer using prostate specific antigen and tumor endothelial marker peptides
|
|
WO2012112691A1
(en)
|
2011-02-15 |
2012-08-23 |
Immune Design Corp. |
Methods for enhancing immunogen specific immune responses by vectored vaccines
|
|
EA027236B1
(ru)
|
2011-04-08 |
2017-07-31 |
Иммьюн Дизайн Корп. |
Иммуногенные композиции и способы применения таких композиций для индукции гуморального и клеточного иммунного ответа
|
|
WO2013019445A2
(en)
|
2011-07-29 |
2013-02-07 |
Health Research, Inc. |
Anti-angiogenic peptides and uses thereof
|
|
US9575053B2
(en)
|
2012-03-30 |
2017-02-21 |
Kyoto University |
Urinary biomarker for use in test for prostate cancer
|
|
HRP20181102T1
(hr)
|
2012-05-16 |
2018-09-07 |
Immune Design Corp |
Cjepiva za hsv-2
|
|
US9725494B2
(en)
*
|
2013-05-17 |
2017-08-08 |
United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Soluble CD27 (sCD27) and the use thereof
|
|
ES2738582T3
(es)
|
2014-02-14 |
2020-01-23 |
Immune Design Corp |
Inmunoterapia del cáncer a través de combinación de inmunoestimulación local y sistémica
|
|
ES2851451T3
(es)
|
2014-05-13 |
2021-09-07 |
Bavarian Nordic As |
Terapia de combinación para tratar cáncer con un poxvirus que expresa un antígeno de tumor y un anticuerpo monoclonal contra TIM-3
|
|
KR20170032373A
(ko)
|
2014-07-15 |
2017-03-22 |
이뮨 디자인 코포레이션 |
Tlr4 작용제 보조제 및 렌티바이러스 벡터를 이용한 프라임-부스트 요법
|
|
US20190183870A1
(en)
|
2016-01-05 |
2019-06-20 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Combination of histone deacetylase inhibitor and immunotherapy
|
|
WO2017136342A1
(en)
|
2016-02-02 |
2017-08-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Fulvestrant for inducing immune-mediated cytotoxic lysis of cancer cells
|
|
MX2018012472A
(es)
|
2016-04-15 |
2019-08-12 |
Alpine Immune Sciences Inc |
Proteinas inmunomoduladoras variantes de ligando icos y sus usos.
|
|
WO2017181152A2
(en)
|
2016-04-15 |
2017-10-19 |
Alpine Immune Sciences, Inc. |
Cd80 variant immunomodulatory proteins and uses thereof
|
|
WO2018022946A1
(en)
|
2016-07-28 |
2018-02-01 |
Alpine Immune Sciences, Inc. |
Cd155 variant immunomodulatory proteins and uses thereof
|
|
WO2018022945A1
(en)
|
2016-07-28 |
2018-02-01 |
Alpine Immune Sciences, Inc. |
Cd112 variant immunomodulatory proteins and uses thereof
|
|
US11471488B2
(en)
|
2016-07-28 |
2022-10-18 |
Alpine Immune Sciences, Inc. |
CD155 variant immunomodulatory proteins and uses thereof
|
|
EP3596116B1
(en)
|
2017-03-16 |
2023-09-06 |
Alpine Immune Sciences, Inc. |
Pd-l1 variant immunomodulatory proteins and uses thereof
|
|
SG11201907769XA
(en)
|
2017-03-16 |
2019-09-27 |
Alpine Immune Sciences Inc |
Cd80 variant immunomodulatory proteins and uses thereof
|
|
KR20190141146A
(ko)
|
2017-03-16 |
2019-12-23 |
알파인 이뮨 사이언시즈, 인코포레이티드 |
Pd-l2 변이체 면역조절 단백질 및 그의 용도
|
|
KR20260047644A
(ko)
|
2017-03-30 |
2026-04-08 |
더 유니버서티 어브 퀸슬랜드 |
키메라 분자 및 그의 용도
|
|
CN111050790B
(zh)
|
2017-08-24 |
2024-07-12 |
巴法里安诺迪克有限公司 |
通过静脉内施用重组mva和抗体治疗癌症的组合疗法
|
|
EP3687561A4
(en)
|
2017-09-01 |
2021-06-09 |
The Australian National University |
"immunoregulatory molecules and uses therefor"
|
|
JP7749319B2
(ja)
|
2017-10-10 |
2025-10-06 |
アルパイン イミューン サイエンシズ インコーポレイテッド |
Ｃｔｌａ－４変異型免疫調節タンパク質およびそれらの使用
|
|
BR112020007542A2
(pt)
|
2017-10-18 |
2020-12-01 |
Alpine Immune Sciences, Inc. |
proteínas imunomoduladoras ligantes de icos variantes e composições e métodos relacionados
|
|
AU2019205273B2
(en)
|
2018-01-03 |
2024-04-04 |
Alpine Immune Sciences, Inc. |
Multi-domain immunomodulatory proteins and methods of use thereof
|
|
WO2019241758A1
(en)
|
2018-06-15 |
2019-12-19 |
Alpine Immune Sciences, Inc. |
Pd-1 variant immunomodulatory proteins and uses thereof
|
|
EP3853247A2
(en)
|
2018-09-19 |
2021-07-28 |
Alpine Immune Sciences, Inc. |
Methods and uses of variant cd80 fusion proteins and related constructs
|
|
JP7555334B2
(ja)
|
2018-10-05 |
2024-09-24 |
バヴァリアン・ノルディック・アクティーゼルスカブ |
組み換えｍｖａ、及び免疫チェックポイントアンタゴニストまたは免疫チェックポイントアゴニストの静脈内投与によって、がんを治療する併用療法
|
|
CA3119503A1
(en)
|
2018-11-20 |
2020-05-28 |
Bavarian Nordic A/S |
Therapy for treating cancer with an intratumoral and/or intravenous administration of a recombinant mva encoding 4-1bbl (cd137l) and/or cd40l
|
|
CA3120868A1
(en)
|
2018-11-30 |
2020-06-04 |
Alpine Immune Sciences, Inc. |
Cd86 variant immunomodulatory proteins and uses thereof
|
|
MX2021012607A
(es)
|
2019-04-17 |
2022-03-11 |
Alpine Immune Sciences Inc |
Metodos y usos de proteinas de fusion de ligando icos (icosl) variante.
|
|
US20230190922A1
(en)
|
2019-11-20 |
2023-06-22 |
Bavarian Nordic A/S |
Recombinant MVA Viruses for Intratumoral and/or Intravenous Administration for Treating Cancer
|
|
EP4146684A2
(en)
|
2020-05-08 |
2023-03-15 |
Alpine Immune Sciences, Inc. |
April and baff inhibitory immunomodulatory proteins with and without a t cell inhibitory protein and methods of use thereof
|
|
US20240279310A1
(en)
|
2021-05-07 |
2024-08-22 |
Alpine Immune Sciences, Inc. |
Methods of dosing and treatment with a taci-fc fusion immunomodulatory protein
|
|
WO2023118508A1
(en)
|
2021-12-23 |
2023-06-29 |
Bavarian Nordic A/S |
Recombinant mva viruses for intraperitoneal administration for treating cancer
|
|
WO2023172883A1
(en)
|
2022-03-07 |
2023-09-14 |
Alpine Immune Sciences, Inc. |
Immunomodulatory proteins of variant cd80 polypeptides, cell therapies thereof and related methods and uses
|
|
KR20250099778A
(ko)
|
2022-10-04 |
2025-07-02 |
알파인 이뮨 사이언시즈, 인코포레이티드 |
자가항체-매개 질환의 치료에 사용하기 위한 돌연변이된 taci-fc 융합 단백질
|